Researchers at PNNL have developed a bacteria testing system called OmniScreen that combines biological and synthetic chemistry with machine learning to hunt down pathogens before they strike.

PNNL researchers are looking for protein signatures that could provide information about how the body's immune system responds to COVID-19.

A zoonotic coronavirus known as SADS-CoV that has killed many pigs has the ability to infect human cells, surprising scientists.

In a new video series this fall, PNNL is highlighting six scientific and technical experts in the national security domain. Each was promoted to Scientist and Engineer Level 5, one of PNNL’s most senior research roles.

PNNL cancer cell biologist Karin Rodland has been recognized by the international Human Proteome Organization.

Twelve researchers from PNNL presented at the 2020 Metabolomics Association of North America virtual conference in mid-September. Their presentations included a plenary talk, keynote talks, oral presentations, posters, and a lightning talk.

Pacific Northwest National Laboratory (PNNL) is part of a continuing National Science Foundation (NSF) team investigating the environmental impact of nanoparticles at the molecular level.

Researchers from PNNL have helped colleagues at OHSU identify lipid molecules required for Zika infection in human cells. The specific lipids involved could also be a clue to why the virus primarily infects brain tissue.

Researchers from 25 institutions around the country, including PNNL, are working to find out how exercise changes the molecular makeup of our cells to generate health benefits.

After 50 years in science and on the eve of retirement, Laboratory Fellow Karin Rodland, a cancer cell biologist at PNNL, is working on experiments she has dreamed about for decades.

Accurate identification of metabolites, and other small chemicals, in biological and environmental samples has historically fallen short when using traditional methods.

A new study using proteogenomics to compare cancerous tissue with normal fallopian tube samples advances insights about the molecular machinery that underlies ovarian cancer.

Artificial intelligence helps researchers identify metabolites, the small molecules that underlie life.

PNNL scientists are on the front lines fighting against biological threats through early detection, diagnosis, and prevention strategies.

PNNL researchers and professional staff led discussions ranging from biothreats and climate change to science careers at the 2020 annual meeting of the American Association for the Advancement of Science, held this year in Seattle.

A new study focusing on the proteins involved in endometrial cancer, commonly known as uterine cancer, offers insights about which patients will need aggressive treatment and which won’t.

The world’s largest scientific society honored Sue B. Clark, a PNNL and WSU chemist, for contributions toward resolving our legacy of radioactive waste, advancing nuclear safeguards, and developing landmark nuclear research capabilities.

PNNL scientists Richard (Dick) Smith and Ljiljana (Lili) Paša-Tolić are recognized by The Analytical Scientist in its 2019 Power List as two of 2019’s top 100 minds in analytical science.

When two powerful earthquakes rocked southern California earlier this month, officials’ attention focused, understandably, on safety. How many people were injured? Were buildings up to code? How good are we at predicting earthquakes?

Patricia Huestis, a collaborator in the Interfacial Dynamics in Radioactive Environments and Materials (IDREAM) Energy Frontier Research Center, has been awarded the DOE Office of Science Graduate Student Research (SCGSR) award.